Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 301-312 of 1,743
Drug study icon
CompletedNCT02935725

PharmacoMRI Effects of AUT00206 in Healthy Males

This study is completed in the United Kingdom. It is testing pharmacoMRI Effects of AUT00206 for Schizophrenia.

In United Kingdom
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Autifony Therapeutics Limited
Condition
Schizophrenia
Drug study icon
CompletedNCT05741710

Use of Methylone for PTSD

This study is completed in the United States, in the United Kingdom, and in Ireland. It is testing use of Methylone for PTSD.

In United Kingdom
PTSDDrugFrom 18 Years to 65 Years
Countries
United States, United Kingdom, Ireland
Sponsor
Transcend Therapeutics
Condition
PTSD
Drug study icon
CompletedNCT01655680

ABT-126 for schizophrenia

This study is completed in the United States, in the United Kingdom, and in Russia. It is testing ABT-126 for schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 20 Years to 65 Years
Countries
United States, United Kingdom, Russia
Sponsor
AbbVie (prior sponsor, Abbott)
Condition
Schizophrenia
Drug study icon
CompletedNCT04693351

Troriluzole for OCD

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.

In United Kingdom
OCDDrugFrom 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT02422186

Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in the United Kingdom, .... It is testing efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In United Kingdom
DepressionDrugOver 65 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT03745820

Safety study of Safety and Efficacy of BIIB104 in schizophrenia

This study is completed in the United States, in the United Kingdom, in Germany, .... It is testing Safety and Efficacy of BIIB104 for schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, United Kingdom, Germany, ...
Sponsor
Biogen
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.